Literature DB >> 26919832

Modulation of an aqueous extract of Chinese medicine prescription Anzi Heji () on ratio of CD4+CD25+FOXP3+ regulatory T cells in anticardiolipin antibody-positive patients with threatened abortion.

Qi-Bin Lu1, Shu Zhu2.   

Abstract

OBJECTIVE: To evaluate Chinese medicine prescription, Anzi Heji (, AZHJ), on immune regulation of CD4+CD25+FOXP3+ regulatory T cells (Tregs) in anticardiolipin antibody (ACA)-positive patients with threatened abortion.
METHODS: Twenty-seven ACA-positive female patients with threatened abortion in the study group were treated with an aqueous extract of AZHJ 125 mL, twice daily for 4 consecutive weeks. The results were compared with control group composed by 15 healthy pregnant women. The ratio of CD4+CD25+FOXP3+ Treg in peripheral blood was identified by flow cytometry. The indicators of ACA were detected by enzyme-linked immunosorbent assay, and embryo development was checked by B-ultrasound.
RESULTS: Compared with the control group, the ratio of CD4+CD25+FOXP3+ Treg cells in the study group was significantly lower before AZHJ treatment (P<0.01) and significantly increased after AZHJ treatment (P<0.01). After treatment, 20 of 27 patients (85%) showed that ACA indicators turned into negative, and 7 cases of quantitative indicators of ACA titers were significantly decreased (P<0.01). Total efficiency of treating miscarriage by AZHJ was 92.59%.
CONCLUSION: AZHJ can regulate the immune function of pregnant women by increasing number of CD4+CD25+FOXP3+ Tregs.

Entities:  

Keywords:  Anzi Heji; CD4+CD25+FOXP3+ regulatory T cells; Chinese medicine prescription; anticardiolipin antibody; threatened abortion

Year:  2016        PMID: 26919832     DOI: 10.1007/s11655-015-2444-3

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  3 in total

1.  Correlation between unexplained recurrent spontaneous abortion with CD4+CD25+ regulatory T-cell and killer cell immunoglobulin-like receptor levels.

Authors:  Xiaozhen Quan; Xuezhou Yang
Journal:  Exp Ther Med       Date:  2017-06-21       Impact factor: 2.447

2.  The potential benefits of Chinese integrative medicine for pregnancy women during the COVID-19 pandemic.

Authors:  Wei Wang; Qing Zhang; Fan Qu
Journal:  Integr Med Res       Date:  2020-06-24

3.  Proteomic Analysis of Differentially Expressed Proteins in the Placenta of Anticardiolipin Antibody- (ACA-) Positive Pregnant Mice after Anzi Heji Treatment.

Authors:  Yazhen Xie; Qibin Lu
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-14       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.